Results
954
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
954 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MUR | zł37.46 | -2.2% | n/a | zł1.5b | zł50.61 | PE8.5x | E24.8% | 5.3% | Real Estate Management and Development | ||
EL | US$103.36 | -2.8% | -46.6% | US$36.4b | US$141.43 | PE57.8x | E26.9% | 2.6% | Household | ||
BLFS | US$20.72 | 3.6% | 5.6% | US$954.5m | US$24.78 | PS7x | E67.7% | n/a | Pharmaceuticals & Biotech | ||
688234 | CN¥47.89 | 5.2% | -33.3% | CN¥20.5b | CN¥68.29 | PE719.5x | E37.0% | n/a | Semiconductors | ||
MEDP | US$443.00 | 10.1% | 82.1% | US$13.4b | US$430.48 | PE43.8x | E14.9% | n/a | Pharmaceuticals & Biotech | ||
OVH | €5.65 | -5.4% | -41.6% | €1.1b | €9.14 | PS1.1x | E103.7% | n/a | Software | ||
IBNSINA | ৳247.30 | 0.08% | -13.7% | ৳7.7b | ৳390.00 | PE11.2x | E19.2% | 2.4% | Pharmaceuticals & Biotech | ||
WIND.N0000 | LK₨20.10 | 0.5% | 14.2% | LK₨27.2b | LK₨24.00 | PE17.5x | E28.6% | 0% | Utilities | ||
CLV | AU$0.49 | 1.5% | -59.3% | AU$82.7m | n/a | PE43x | E54.6% | 0% | Materials | ||
SPOG | NOK 56.10 | 1.7% | 17.6% | NOK 1.2b | NOK 63.33 | PB0.2x | E29.4% | 9.6% | Banks | ||
NOTION | RM 1.91 | -6.8% | 478.8% | RM 996.2m | RM 3.28 | PS2.6x | E54.6% | 1.0% | Tech | ||
CRS | US$110.97 | 5.9% | 95.3% | US$5.4b | US$123.60 | PE42x | E27.4% | 0.7% | Materials | ||
5110 | ر.س16.30 | 1.0% | -28.4% | ر.س67.9b | ر.س19.83 | PE25.1x | E44.8% | 4.3% | Utilities | ||
6088 | HK$3.52 | -0.8% | 144.4% | HK$24.9b | HK$3.15 | PE24.8x | E29.2% | 0% | Tech | ||
DGC | ₫125,500.00 | 0.4% | 75.3% | ₫47.7t | ₫134,783.33 | PE17x | E22.4% | 3.2% | Materials | ||
ENJU3 | R$2.24 | 10.3% | 77.8% | R$453.9m | R$2.25 | PS2.1x | E90.9% | n/a | Media | ||
GENL | UK£0.95 | -2.2% | -6.8% | UK£263.6m | UK£1.02 | PS4x | E53.4% | 0% | Energy | ||
4974 | JP¥1,172.00 | 4.4% | -30.5% | JP¥141.1b | JP¥1,566.67 | PE95.4x | E22.1% | 1.5% | Pharmaceuticals & Biotech | ||
RYA | €17.12 | 1.7% | 3.4% | €19.3b | €23.83 | PE10.1x | E10.3% | 2.1% | Transportation | ||
688076 | CN¥69.34 | -4.8% | 99.2% | CN¥15.1b | CN¥62.25 | PE72.7x | E35.6% | 0.6% | Pharmaceuticals & Biotech | ||
2160 | HK$0.89 | 2.3% | -57.6% | HK$2.1b | HK$2.19 | PS5.9x | E98.6% | n/a | Healthcare | ||
2124 | JP¥714.00 | 3.0% | 8.6% | JP¥114.3b | JP¥850.00 | PE19.1x | E18.2% | 3.6% | Commercial Services | ||
2130 | JP¥939.00 | 5.2% | -42.4% | JP¥12.0b | JP¥850.00 | PE95.1x | E38.9% | 3.4% | Media | ||
LEVI | US$19.11 | -0.1% | 40.6% | US$7.6b | US$23.02 | PE52.8x | E39.3% | 2.5% | Consumer Durables |